Unnamed stage
$4m
Birth rates are plummeting globally — this Australian IVF trial wants to change that
Proto Axiom has put $4 million into Sydney IVF biotech JumpStart Fertility, a UNSW spin-out, to pay for human trials of a treatment aimed at age-related fertility decline.